Improving the estimation of tuberculosis infection prevalence using T-cell-based assay and mixture models.

作者: N. Dendukuri , M. Pai , H. L. Rieder , S. Kalantri , L. Wang

DOI:

关键词:

摘要: BACKGROUND The prevalence of latent tuberculosis infection (LTBI) is traditionally estimated using the tuberculin skin test (TST). Highly specific blood-based interferon-gamma release assays (IGRAs) are now available and could enhance estimation LTBI in combination with model-based methods.

参考文章(26)
P S Vaidyanathan, P S Jagannatha, V K Chadha, P Jagota, PPD RT23 for tuberculin surveys in India. International Journal of Tuberculosis and Lung Disease. ,vol. 7, pp. 172- 179 ,(2003)
H L Rieder, B E Neuenschwander, M Zwahlen, R R Engel, S J Kim, Trends in the prevalence of infection with mycobacterium tuberculosis in Korea from 1965 to 1995: an analysis of seven surveys by mixture models. International Journal of Tuberculosis and Lung Disease. ,vol. 4, pp. 719- 729 ,(2000)
D Menzies, M Pai, R Joshi, Risk of tuberculosis infection and disease associated with work in health care settings International Journal of Tuberculosis and Lung Disease. ,vol. 11, pp. 593- 605 ,(2007)
T. Arnadottir, H.L. Rieder, A. Trébucq, H.T. Waaler, Guidelines for conducting tuberculin skin test surveys in high prevalence countries Tubercle and Lung Disease. ,vol. 77, pp. 1- 19 ,(1996) , 10.1016/S0962-8479(96)90127-6
Madhukar Pai, Lee W Riley, John M Colford, Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review Lancet Infectious Diseases. ,vol. 4, pp. 761- 776 ,(2004) , 10.1016/S1473-3099(04)01206-X
Steven N. Goodman, Toward Evidence-Based Medical Statistics. 2: The Bayes Factor Annals of Internal Medicine. ,vol. 130, pp. 1005- 1013 ,(1999) , 10.7326/0003-4819-130-12-199906150-00019
Rajnish Joshi, Arthur L Reingold, Dick Menzies, Madhukar Pai, Tuberculosis among Health-Care Workers in Low- and Middle-Income Countries: A Systematic Review PLOS Medicine. ,vol. 3, pp. 2376- 2391 ,(2006) , 10.1371/JOURNAL.PMED.0030494
Steven N Goodman, Introduction to Bayesian methods I: measuring the strength of evidence. Clinical Trials. ,vol. 2, pp. 282- 290 ,(2005) , 10.1191/1740774505CN098OA